Endovascular Transvenous versus Open Femoropopliteal Bypass
Open Access
Abstract
Background and Objectives: Lower extremity arterial disease is one of the most prevalent manifestations of atherosclerosis. The results from numerous studies regarding the best revascularization method of an occluded superficial femoral artery have been conflicting. The aim of this study was to compare the patency of transvenous endovascular with open femoropopliteal bypass, both with vein and prosthetic grafts. To our knowledge, a direct patency comparison between transvenous endovascular and open femoropopliteal bypass has not been published. This could help elucidate which method is preferable and in which cases. Materials and Methods: Patients with complex TASC-C and D SFA lesions were offered endovascular transvenous or open bypass. A total of 384 consecutive patients with PAD requiring surgical treatment were evaluated for inclusion in this study. Three-year follow-up data were collected for 52 endovascular procedures, 80 prosthetic grafts, and 44 venous bypass surgeries. Bypass patency was investigated by Duplex US every 6 months. Kaplan–Meier plots were used to analyze primary, primary-assisted, and secondary patency for endovascular transvenous, autovenous, and prosthetic bypasses. Results: Primary, primary-assisted, and secondary patency in venous group at 3 years was 70.5%, 77.3%, and 77.3%, respectively. In the endovascular transvenous group, primary, primary-assisted, and secondary patency at 3 years was 46.2%, 69.2%, and 76.9%, respectively. The lowest patency rates at 3 years were noted in the prosthetic graft group with 22.5% primary, 26.6% primary-assisted, and 28.2% secondary patency. Conclusions: The saphenous vein is the best graft to perform in above-the-knee femoropopliteal bypass. Transvenous endovascular bypass is a viable option with comparable primary-assisted and secondary patency. Primary patency is substantially lower for endovascular transvenous compared to venous bypass. Patients treated with endovascular transvenous bypass will require a significant number of secondary procedures to provide optimal patency. Prosthetic grafts should only be used if no other option for bypass is available.Keywords
This publication has 22 references indexed in Scilit:
- Technique and early results of percutaneous femoropopliteal bypass with stent graftJournal of Vascular Surgery Cases, Innovations and Techniques, 2023
- ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year ResultsCardioVascular and Interventional Radiology, 2023
- Beyond Wires and Knives: What Can We Learn From BEST-CLI and BASIL-2?European Journal of Vascular and Endovascular Surgery, 2023
- Peripheral Artery Disease: A Comprehensive Updated ReviewCurrent Problems in Cardiology, 2022
- Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral arteryJournal of Vascular Surgery, 2021
- Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypassJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2021
- Arm Vein versus Small Saphenous Vein for Lower Extremity Bypass in the Absence of Both Great Saphenous VeinsAnnals of Vascular Surgery, 2021
- One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypassJournal of Vascular Surgery, 2020
- Graft type for femoro-popliteal bypass surgeryCochrane Database of Systematic Reviews, 2018
- Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment receivedJournal of Vascular Surgery, 2010